Plant cell culture technologies
The industrial exploitation of plant cell, tissue and organ cultures is now a actuality and the brand new applied sciences are already in place and creating quickly. Their emergence has supplied new views and sharpened the main focus of the methods through which plant cell and tissue tradition can assist man. Along with the thrilling new developments in plant molecular biology, these in vitro procedures ought to enable plant bio technologists to ‘design’ crops and plant merchandise and exploit the total industrial potential of plant cell cultures.
PROPERTIES
High quality Stage
200
organic supply
algae (Rhodophyceae)
type
powder
utility(s)
cell tradition | mammalian: appropriate
cell tradition | plant: appropriate
microbiology: appropriate
transition temp
congealing temperature <38 °C (1.5% in H2O)
suitability
microbiology examined
Featured Business
Agriculture
storage temp.
room temp
DESCRIPTION
Common description
Utility
Agar has been used:
- as a reference commonplace industrial agar to match the physio-chemical, gelling properties of alkali-treated agar from Gracilaria tenuistipitata
- as a part within the seed germination medium and rooting medium for commercially obtainable soybean (Glycine max (L.) Merr) seeds
- as a part of development media for B. subtilis mutant pressure MTC871 based mostly biofilm colonies
- as a bacteriological agar part to arrange half power Murashige-Skoog (MS 50%) medium for Echinocactus platycanthus seeds tradition
Typical working focus: 6-12g/L.
Packaging
Biochem/physiol Actions
Different Notes
Bacterial Ailments
Some micro organism inflicting infecting Hashish crops embrace Pseudomonas syringae and Xanthomonas campestris pv. Hashish. The signs of Pseudomonas syringae are small water-soaked leaf spots which will enlarge alongside the veins, turning brown. The Xanthomonas campestris causes leaf spots and wilting in crops.
Fungal Ailments
A few of the main hashish infecting fungus and ailments attributable to them are:
- Fusarium oxysporum f.sp. Hashish causes wilt whose signs embrace yellowing of leaves, poor development, and wilt.
- Pythium illness causes root rot and damping-off illness whose signs fluctuate from small roots lesions, extreme root injury, stunted development, to yellowing of leaves. Additional, damping-off impacts younger seedlings.
- Sclerotinia sclerotiorum causes hemp canker whose preliminary signs embrace watersoaked lesions on stalks and branches that may later trigger cankers. Generally cottony white mycelium and black sclerotia may seem.
- Sphaeorotheca macularis or Leveillula taurica causes powdery mildew. It’s one of the crucial widespread foliar ailments of hashish. Its signs embrace powdery development on the floor of leaves that later turns brown.
- The hashish plant can be affected by Alternaria species, which causes leaf spot and brown blight ailments.
Viral and Viroid Ailments
Viruses affecting hashish embrace Hop mosaic virus (HpMV), Apple mosaic virus (ApMV), Hop stunt viroid (HSVd), Hop latent viroid, Arabis mosaic virus (ArMV), Alfalfa mosaic virus (AMV), Tobacco mosaic virus (TMC), Cucumber mosaic virus (CMV), and phytoplasmas.
The viruses may cause extreme crop losses, cut back development, or have an effect on the yield and high quality of crops. The widespread signs of viruses embrace yellow and inexperienced mosaic patterns on the leaves of Hashish and curling, distortion, and narrowing of younger leaves. Phytoplasmas primarily trigger extreme shoot proliferation and stunted development.
CD273 Monoclonal Antibody |
|||
E10-32031 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
CD273 Monoclonal Antibody |
|||
E10-32032 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
Mouse anti-CD273 Antibody |
|||
DL99420A-100ul | DL Develop | 100 ul | EUR 299 |
Description: B7DC; CD273; PDCD1L2; PDL2; Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; PDCD1 ligand 2; Programmed death ligand 2; Butyrophilin B7-DC; B7-DC; CD273 |
Mouse anti-CD273 Antibody |
|||
DL99420A-50ul | DL Develop | 50 ul | EUR 210 |
Description: B7DC; CD273; PDCD1L2; PDL2; Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; PDCD1 ligand 2; Programmed death ligand 2; Butyrophilin B7-DC; B7-DC; CD273 |
Mouse anti-CD273 Antibody |
|||
DL99442A-100ul | DL Develop | 100 ul | EUR 299 |
Description: B7DC; CD273; PDCD1L2; PDL2; Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; PDCD1 ligand 2; Programmed death ligand 2; Butyrophilin B7-DC; B7-DC; CD273 |
Mouse anti-CD273 Antibody |
|||
DL99442A-50ul | DL Develop | 50 ul | EUR 210 |
Description: B7DC; CD273; PDCD1L2; PDL2; Programmed cell death 1 ligand 2; PD-1 ligand 2; PD-L2; PDCD1 ligand 2; Programmed death ligand 2; Butyrophilin B7-DC; B7-DC; CD273 |
PE Anti-Human CD273/PD-L2 Antibody |
|||
DL21928F-20Tests | DL Develop | 20Tests | EUR 222.5 |
Description: CD273, known as B7-DC, is also called programmed death ligand 2 (PDL2). This ligand is a 25 kD type I transmembrane protein and a member of B7 family within the immunoglobulin receptor superfamily and is expressed on a subset of dendritic cells, liver and a small subset of macrophages as well as a few transformed cell lines. CD273 has been reported to be stimulatory on dendritic cells when cross-linked and to inhibit T cell activation upon engaging the PD-1 receptor. CD273 has also been reported to bind to an alternative receptor and to mediate T cell activation through such non-PD1 mediated interactions. |
PE Anti-Human CD273/PD-L2 Antibody |
|||
DL21928F-50Tests | DL Develop | 50Tests | EUR 320 |
Description: CD273, known as B7-DC, is also called programmed death ligand 2 (PDL2). This ligand is a 25 kD type I transmembrane protein and a member of B7 family within the immunoglobulin receptor superfamily and is expressed on a subset of dendritic cells, liver and a small subset of macrophages as well as a few transformed cell lines. CD273 has been reported to be stimulatory on dendritic cells when cross-linked and to inhibit T cell activation upon engaging the PD-1 receptor. CD273 has also been reported to bind to an alternative receptor and to mediate T cell activation through such non-PD1 mediated interactions. |
APC Anti-Human CD273/PD-L2 Antibody |
|||
DL21929F-20Tests | DL Develop | 20Tests | EUR 245 |
Description: CD273, known as B7-DC, is also called programmed death ligand 2 (PDL2). This ligand is a 25 kD type I transmembrane protein and a member of B7 family within the immunoglobulin receptor superfamily and is expressed on a subset of dendritic cells, liver and a small subset of macrophages as well as a few transformed cell lines. CD273 has been reported to be stimulatory on dendritic cells when cross-linked and to inhibit T cell activation upon engaging the PD-1 receptor. CD273 has also been reported to bind to an alternative receptor and to mediate T cell activation through such non-PD1 mediated interactions. |
APC Anti-Human CD273/PD-L2 Antibody |
|||
DL21929F-50Tests | DL Develop | 50Tests | EUR 357.5 |
Description: CD273, known as B7-DC, is also called programmed death ligand 2 (PDL2). This ligand is a 25 kD type I transmembrane protein and a member of B7 family within the immunoglobulin receptor superfamily and is expressed on a subset of dendritic cells, liver and a small subset of macrophages as well as a few transformed cell lines. CD273 has been reported to be stimulatory on dendritic cells when cross-linked and to inhibit T cell activation upon engaging the PD-1 receptor. CD273 has also been reported to bind to an alternative receptor and to mediate T cell activation through such non-PD1 mediated interactions. |
Mouse Anti-Human CD273 (PD-L2) mAb |
|||
CM031-100ug | SAB | 100ug | EUR 250.8 |
Mouse Anti-Human CD273 (PD-L2) mAb |
|||
CM031-25ug | SAB | 25ug | EUR 154.8 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
abx140405-01mg | Abbexa | 0.1 mg | EUR 427.2 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
abx412031-01mg | Abbexa | 0.1 mg | EUR 610.8 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
abx414235-025mg | Abbexa | 0.25 mg | EUR 678 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
abx414420-02mg | Abbexa | 0.2 mg | EUR 678 |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody |
|||
abx414421-01mg | Abbexa | 0.1 mg | EUR 526.8 |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7546-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7546-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7546SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7581-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Recognizes a protein identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7581-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: Recognizes a protein identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V7581SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Recognizes a protein identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V8176-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V8176-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
V8176SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
|||
R32447 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: Programmed cell death 1 ligand 2 (also known as PD-L2, B7-DC) is a protein that in humans is encoded by the PDCD1LG2 gene. It is mapped to chromosome 9p24.2. PD-L2 is one of two ligands for programmed death-1 (PD-1), a member of the CD28 family of immuno-receptors. Northern blot analysis detect wide expression of PDL2, with highest levels in placenta, heart, pancreas, lung, and liver, and lower levels in spleen, lymph nodes, and thymus. PDL2 negatively regulates T cells and plays an essential role in immune tolerance. |
Programmed Cell Death 1 Ligand 2 (CD273) Antibody (PE) |
|||
abx140428-100tests | Abbexa | 100 tests | EUR 577.2 |